2021 Prior Authorization Criteria ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) Drug Products Affected: Methamphetamine Covered Uses All FDA-approved indications not otherwise excluded from Part D. Exclusion Criteria N/A Required Medical Information N/A Age Restrictions N/A Prescriber Restrictions N/A Coverage Duration Through the end of the Plan Contract Year Other Criteria N/A AIDS RELATED WEIGHT LOSS Drug Products Affected: Dronabinol, Serostim, Syndros Covered Uses All FDA-approved indications not otherwise excluded from Part D. Exclusion Criteria N/A Required Medical Information N/A Age Restrictions N/A Prescriber Restrictions N/A Coverage Duration Through the end of the Plan Contract Year Other Criteria N/A Y0043_N00016976_C Updated: 09/2020 1
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
2021 Prior Authorization Criteria
ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)
Drug Products Affected: Methamphetamine
Covered Uses All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria N/A
Required Medical Information
N/A
Age Restrictions N/A
Prescriber Restrictions N/A
Coverage Duration Through the end of the Plan Contract Year
Other Criteria N/A
AIDS RELATED WEIGHT LOSS
Drug Products Affected: Dronabinol, Serostim, Syndros
Covered Uses All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria N/A
Required Medical Information
N/A
Age Restrictions N/A
Prescriber Restrictions N/A
Coverage Duration Through the end of the Plan Contract Year
Other Criteria N/A
Y0043_N00016976_C Updated: 09/2020
1
ANTICONVULSANTS
Drug Products Affected: Epidiolex
Covered Uses All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria N/A
Required Medical Information
N/A
Age Restrictions N/A
Prescriber Restrictions N/A
Coverage Duration Through the end of the Plan Contract Year
Other Criteria N/A
ANTI-INFECTIVES
Drug Products Affected: Arikayce
Covered Uses All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria N/A
Required Medical Information
N/A
Age Restrictions N/A
Prescriber Restrictions N/A
Coverage Duration Through the end of the Plan Contract Year
Other Criteria N/A
ANTINEOPLASTICS
Drug Products Affected: Targretin
Covered Uses All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria N/A
Required Medical Information
N/A
Age Restrictions N/A
Prescriber Restrictions N/A
Coverage Duration Through the end of the Plan Contract Year
Other Criteria N/A
2
BENIGN PROSTATIC HYPERPLASIA
Drug Products Affected: Tadalafil 2.5 mg, 5 mg tablets
Covered Uses All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria Stand Alone Erectile Dysfunction
Required Medical Information
N/A
Age Restrictions N/A
Prescriber Restrictions N/A
Coverage Duration Through the end of the Plan Contract Year
Other Criteria N/A
BONE DISORDERS
Drug Products Affected: Xgeva
Covered Uses All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria N/A
Required Medical Information
N/A
Age Restrictions N/A
Prescriber Restrictions N/A
Coverage Duration Through the end of the Plan Contract Year
Other Criteria N/A
CARISOPRODOL PRODUCTS
Drug Products Affected: Aspirin/Carisoprodol; Aspirin/Carisoprodol/Codeine Phosphate, Carisoprodol
Covered Uses All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria N/A
Required Medical Information
N/A
Age Restrictions N/A
Prescriber Restrictions N/A
Coverage Duration Through the end of the Plan Contract Year
Covered Uses All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria Diagnosis of Non-Cancer related pain
Required Medical Information
Diagnosis of Cancer pain. Documentation of tolerance to around-the-clock opioid therapy for their underlying persistent pain.
Age Restrictions N/A
Prescriber Restrictions
Patient under care of Oncologist or Hospice/Palliative Care Specialist.
Coverage Duration Through the End of the Plan Contract Year
Other Criteria N/A
XOLAIR
Drug Products Affected: Xolair
Covered Uses All FDA-approved indications not otherwise excluded from Part D.
Exclusion Criteria N/A
Required Medical Information
N/A
Age Restrictions N/A
Prescriber Restrictions
N/A
Coverage Duration Through the End of the Plan Contract Year
Other Criteria N/A
You must reside in the Kaiser Permanente Medicare health plan service area in which you enroll.
11
Notice of nondiscrimination Kaiser Permanente complies with applicable federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. Kaiser Permanente does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. We also:
• Provide no cost aids and services to people with disabilities to communicate effectively with us, such as: ♦ Qualified sign language interpreters. ♦ Written information in other formats, such as large print, audio, and accessible
electronic formats. • Provide no cost language services to people whose primary language is not English,
such as: ♦ Qualified interpreters. ♦ Information written in other languages.
If you need these services, call Member Services at 1-800-443-0815 (TTY 711), 8 a.m. to 8 p.m., seven days a week.
If you believe that Kaiser Permanente has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with our Civil Rights Coordinator by writing to One Kaiser Plaza, 12th Floor, Suite 1223, Oakland, CA 94612 or calling Member Services at the number listed above. You can file a grievance by mail or phone. If you need help filing a grievance, our Civil Rights Coordinator is available to help you. You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at: U.S. Department of Health and Human Services, 200 Independence Avenue SW., Room 509F, HHH Building, Washington, DC 20201, 1-800-368-1019, 800-537-7697 (TDD). Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.
Multi-language Interpreter Services English ATTENTION: If you speak a language other than English, language assistance services, free of charge, are available to you. Call 1-800-443-0815 (TTY: 711).
SpanishATENCIÓN: si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-800-443-0815 (TTY: 711).
Vietnamese CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-800-443-0815 (TTY: 711).
Tagalog PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 1-800-443-0815 (TTY: 711).
Korean 주의 : 한국어를 사용하시는 경우 , 언어 지원 서비스를 무료로 이용하실 수 있습니다 .
1-800-443-0815 (TTY: 711) 번으로 전화해 주십시오 .
Armenian ՈՒՇԱԴՐՈՒԹՅՈՒՆ՝ Եթե խոսում եք հայերեն, ապա ձեզ անվճար կարող են տրամադրվել լեզվական աջակցության ծառայություններ: Զանգահարեք 1-800-443-0815 (TTY (հեռատիպ)՝ 711):
Russian ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 1-800-443-0815 (телетайп: 711).